Bioxytran has reported positive results from its completed phase 2 trial of ProLectin‑M, showing rapid and sustained viral clearance in subjects with laboratory‑confirmed acute viral infection. The ...
( OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects ...
Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst - POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 /IGC Pharma, Inc. (NYSE American:IGC) ( ...
POTOMAC, MARYLAND / ACCESS Newswire / February 2, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), today ...
Adds world renowned GNA site to broaden genetic diversity and strengthen path toward 2026 data catalyst - POTOMAC, MARYLAND / ACCESS Newswire / February 9, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ...
CEO Andrew Obenshain said the company is preparing for a second-half phase 3 readout for lanifibranor in metabolic dysfunction-associated steatohepatitis (MASH), describing the trial as fully enrolled ...
On February 12, the second - phase project of the ±200 kV DC power transmission project from Yangzhou to Zhenjiang in Jiangsu ...
Early-phase oncology trials carry substantial scientific and commercial risk in cancer drug development. Getting them right ...
SMM Hydrogen Energy Express] On February 12, the third phase of the Goldwind Xing'an League Green Hydrogen to Green Methanol ...
2d
Global energy leaders join Energy Connects Advisory Board to drive the next phase of dynamic growth
DUBAI, UNITED ARAB EMIRATES, January 20, 2026 /EINPresswire.com/ -- Energy Connects, a global energy media platform by ...
As it underwent a growth spurt in the early 2020s, graphic design platform Canva turned to 1Password to manage identity across its expanding organisation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results